Phase 3 Program

Fulcrum Therapeutics Announces Topline Results from Phase 3 ...

“In light of these results, we plan to suspend the losmapimod program in FSHD. We would like to thank the FSHD patients who participated in ...

Gilead's Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV ...

... Phase 3 Trial. ... The Phase 2 and 3 program, consisting of PURPOSE 1-5, is assessing ...

Blueprint Medicines Announces Top-line Results from Phase 3 ...

The VOYAGER trial did not meet the primary endpoint of an improvement in progression-free survival (PFS) for avapritinib versus regorafenib.

TREMFYA® (guselkumab) demonstrates superiority versus ...

TREMFYA® (guselkumab) demonstrates superiority versus STELARA® (ustekinumab) in Phase 3 Crohn's disease program · Data from GALAXI 2 & 3 showed ...

Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program ...

Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder ...

Cassava Sciences Announces Completion of an Interim Safety ...

Patients with mild-to-moderate Alzheimer's disease dementia who met study eligibility criteria were recruited into the Phase 3 program from ...

EXPLORE Phase 3 Electives - MD Program - Washington University

EXPLORE Phase 3 Electives. Phase 3 students can reserve substantial periods of consecutive or non-consecutive time to pursue a project of interest for credit ...

Viking's obesity drug advancing to phase 3 with $300M for trials

Viking Therapeutics is accelerating its plans to advance its obesity drug VK2735 into phase 3 trials, with the clinical program estimated to ...

jCyte Announces Plans to Launch Phase 3 Clinical Trial of Cell ...

Known as retinal progenitors, the company's jCells® are designed to preserve photoreceptors in people with retinitis pigmentosa (RP) and ...

Stealth BioTherapeutics Announces First Patient Enrolled in Global ...

It has enrolled and dosed its first patient in the ReNEW trial (NCT06373731) as part of its Phase 3 clinical program for elamipretide in patients with dry age- ...

INDs for Phase 2 and Phase 3 Studies - FDA

A description of the stability program to support the drug substance under clinical investigation in phase 2 should be submitted that includes a list of tests, ...

New Phase 3 Clinical Trial Opportunity for People Living with ...

GlaxoSmithKline (GSK) is launching two new phase 3 clinical trials called B Well-1 and B Well-2, which will test an experimental drug, bepirovirsen, as a ...

350 HOUR PROGRAM /Phase III Schedule - Rutgers Alternate Route

Phase 3 will open for registration in Winter 2025.

MoonLake Immunotherapeutics starts Phase 3 VELA program of the ...

Sonelokimab, an investigational Nanobody designed to treat inflammatory disease, in patients with moderate-to-severe hidradenitis suppurativa (HS).

Ionis Announces Pivotal Phase 3 Trial Design for ION582 in ...

At the FAST Global Science Summit this weekend ( November 8-9 ), Ionis will provide an update to the community on the Phase 3 program and review ...

Phase 3 - UND School of Medicine & Health Sciences

The approved schedule will be e-mailed to the student by the campus office. Instructions for Filing Phase 3 Schedule Changes(Open this section). Schedule ...

Q&A: Alumis Inc. Initiates Phase 3 Clinical Program for ESK-001 in ...

This topical therapy, a pan-Janus kinase (JAK) inhibitor, is specifically indicated for adults suffering from moderate to severe chronic hand ...

Incyte Announces 52-Week Data From the Phase 3 TRuE-V ...

26, 2022-- Incyte (Nasdaq:INCY) today announced new 52-week results from its pivotal Phase 3 TRuE-V clinical trial program evaluating ruxolitinib cream ( ...

Efruxifermin for MASH | Clinical Trials - Akero Therapeutics

We are currently enrolling three clinical trials as part of a Phase 3 SYNCHRONY program evaluating EFX for the treatment of pre-cirrhotic MASH.

Phase 3 - Sustainment - TN.gov

In Phase 3, EPP and district partners focus on enhancing partnership work in support of ongoing improved outcomes for educator candidates.